Patents Assigned to VERO BIOTECH LLC
  • Patent number: 11672938
    Abstract: Start-up protocols for a device and method for administering NO is described.
    Type: Grant
    Filed: July 16, 2019
    Date of Patent: June 13, 2023
    Assignee: VERO Biotech LLC
    Inventors: David H. Fine, Edward Bromberg, Ryan Denton, Jason White, Lucas G. Gamero, Bryan Johnson, Gregory Vasquez, Doug Sonosky
  • Publication number: 20220088342
    Abstract: A method for delivering nitric oxide therapy to a subject can include administering a composition including a nitric-oxide releasing agent and silica to the subject and releasing a therapeutic amount of nitric oxide from the composition.
    Type: Application
    Filed: August 30, 2021
    Publication date: March 24, 2022
    Applicant: VERO Biotech LLC
    Inventor: David H. FINE
  • Patent number: 11243197
    Abstract: A device and method for calibrating a NO delivery device using NO and NO2 measurements, without using a known standard.
    Type: Grant
    Filed: July 16, 2019
    Date of Patent: February 8, 2022
    Assignee: VERO Biotech LLC
    Inventors: David H. Fine, Edward Bromberg, Thorsten Schmidt, Ryan Denton
  • Publication number: 20220016379
    Abstract: A method and device can alternately deliver high concentration of nitric oxide and oxygen-enriched air.
    Type: Application
    Filed: March 29, 2021
    Publication date: January 20, 2022
    Applicant: VERO Biotech LLC
    Inventors: David H. FINE, Lee LEICHTER
  • Publication number: 20220008679
    Abstract: Various systems and devices for generating nitric oxide are disclosed herein. According to one embodiment, the device includes a body having an inlet, an outlet, and a porous solid matrix positioned with the body. The porous solid matrix is coated with an aqueous solution of an antioxidant, wherein the inlet is configured to receive a gas flow and fluidly communicate the gas flow to the outlet through the solid matrix to convert nitrogen dioxide in the gas flow into nitric oxide. The porous solid matrix allows the device to be used in any orientation. Additionally, the porous solid matrix provides a rigid structure suitable to withstand vibrations and abuse without compromising device functionality.
    Type: Application
    Filed: February 22, 2021
    Publication date: January 13, 2022
    Applicant: VERO Biotech LLC
    Inventors: David H. FINE, Bryan JOHNSON, Gregory VASQUEZ
  • Patent number: 11208326
    Abstract: Dinitrogen tetroxide (N2O4) is synthesized in an apparatus by the reaction of concentrated nitric acid with copper. Oxygen is applied as a carrier gas to convert NO to NO2, and water vapor is removed with a tube dryer. A molecular sieve is applied to reduce and remove impurities.
    Type: Grant
    Filed: July 18, 2019
    Date of Patent: December 28, 2021
    Assignee: VERO Biotech LLC
    Inventors: David H. Fine, Thorsten Schmidt, Bryan Johnson, Alessandra Miranda, Edward Bromberg, Marjorie Nelson
  • Publication number: 20210393915
    Abstract: Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. A nitric oxide delivery system that converts nitrogen dioxide to nitric oxide employs a surface-active material, such as silica gel, coated with an aqueous solution of antioxidant, such as ascorbic acid.
    Type: Application
    Filed: August 27, 2021
    Publication date: December 23, 2021
    Applicant: VERO Biotech LLC
    Inventors: David P. ROUNBEHLER, David H. FINE
  • Patent number: 11202880
    Abstract: Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. A nitric oxide delivery system that converts nitrogen dioxide to nitric oxide employs a surface-active material, such as silica gel, coated with an aqueous solution of antioxidant, such as ascorbic acid.
    Type: Grant
    Filed: October 26, 2020
    Date of Patent: December 21, 2021
    Assignee: VERO Biotech LLC
    Inventors: David P. Rounbehler, David H. Fine
  • Publication number: 20210386958
    Abstract: Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. A nitric oxide delivery system that converts nitrogen dioxide to nitric oxide employs a surface-active material, such as silica gel, coated with an aqueous solution of antioxidant, such as ascorbic acid.
    Type: Application
    Filed: August 27, 2021
    Publication date: December 16, 2021
    Applicant: VERO Biotech LLC
    Inventors: David P. ROUNBEHLER, David H. FINE
  • Patent number: 11154210
    Abstract: A method for treating pulmonary arterial hypertension in a patient can include determining whether a patient with pulmonary arterial hypertension has an enlarged right ventricle or right ventricular dysfunction, where the patient has previously been administered a prostanoid and weaning the patient off of the prostanoid if the patient does not have an enlarged right ventricle or right ventricular dysfunction.
    Type: Grant
    Filed: January 7, 2013
    Date of Patent: October 26, 2021
    Assignee: VERO Biotech LLC
    Inventors: Tammy Watts, Robert F. Roscigno, David H. Fine, Lewis J. Rubin
  • Publication number: 20210316107
    Abstract: Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. A nitric oxide delivery system that converts nitrogen dioxide to nitric oxide employs a surface-active material, such as silica gel, coated with an aqueous solution of antioxidant, such as ascorbic acid.
    Type: Application
    Filed: October 26, 2020
    Publication date: October 14, 2021
    Applicant: VERO Biotech LLC
    Inventors: David P. ROUNBEHLER, David H. FINE
  • Patent number: 11103669
    Abstract: A method for delivering nitric oxide therapy to a subject can include administering a composition including a nitric-oxide releasing agent and silica to the subject and releasing a therapeutic amount of nitric oxide from the composition.
    Type: Grant
    Filed: November 23, 2015
    Date of Patent: August 31, 2021
    Assignee: Vero Biotech LLC
    Inventor: David H. Fine
  • Patent number: 11000484
    Abstract: Various methods for diagnosing and treating heart conditions are disclosed herein. According to one method, nitric oxide is delivered to a patient's lungs when the patient has one or more symptoms of a heart condition. The patient is diagnosed as suffering from a heart condition when a symptom of a heart condition subsides after nitric oxide delivery.
    Type: Grant
    Filed: July 24, 2009
    Date of Patent: May 11, 2021
    Assignee: Vero Biotech LLC
    Inventor: David H. Fine
  • Publication number: 20210121655
    Abstract: A nitric oxide delivery system can include a cassette which is a single use disposable component used to store liquid N2O4 activate upon operator demand, convert N2O4 to NO2 via a heating element(s) controlled by a console to deliver NO2 at a controlled flow rate, direct concentrated NO2 to a contained pair of conversion cartridges and exhaust NO gas to the console for delivery to the patient.
    Type: Application
    Filed: August 7, 2020
    Publication date: April 29, 2021
    Applicant: VERO Biotech LLC
    Inventors: Barry N. GELLMAN, Eddie TAJUDEEN, Lucas GAMERO, Joshua HOPKINS, Edward E.A. BROMBERG, Ryan DENTON, Bryan J. JOHNSON, David FINE
  • Publication number: 20210100972
    Abstract: A device and method for treating high-altitude sickness can include a handheld device, and can deliver a therapeutic amount of nitric oxide to an individual's lungs in order to minimize or treat high-altitude sickness. The device is self-contained and portable, which allows an individual to carry and use the device in high-altitude or other low-oxygen environments.
    Type: Application
    Filed: September 18, 2020
    Publication date: April 8, 2021
    Applicant: VERO Biotech LLC
    Inventors: David H. FINE, Gregory VASQUEZ, Bryan JOHNSON
  • Patent number: 10960168
    Abstract: A method and device can alternately deliver high concentration of nitric oxide and oxygen-enriched air. A method of providing a therapeutic amount of nitric oxide to a mammal can include delivering one or more breaths of a therapeutic amount of nitric oxide to the mammal and delivering one or more breaths of an amount of oxygen-enriched air to the mammal immediately after the one or more breaths of the therapeutic amount of nitric oxide.
    Type: Grant
    Filed: August 13, 2009
    Date of Patent: March 30, 2021
    Assignee: VERO Biotech LLC
    Inventors: David H. Fine, Lee Leichter
  • Patent number: 10926054
    Abstract: Various systems and devices for generating nitric oxide are disclosed herein. According to one embodiment, the device includes a body having an inlet, an outlet, and a porous solid matrix positioned with the body. The porous solid matrix is coated with an aqueous solution of an antioxidant, wherein the inlet is configured to receive a gas flow and fluidly communicate the gas flow to the outlet through the solid matrix to convert nitrogen dioxide in the gas flow into nitric oxide. The porous solid matrix allows the device to be used in any orientation. Additionally, the porous solid matrix provides a rigid structure suitable to withstand vibrations and abuse without compromising device functionality.
    Type: Grant
    Filed: March 24, 2017
    Date of Patent: February 23, 2021
    Assignee: Vero Biotech LLC
    Inventors: David H. Fine, Bryan Johnson, Gregory Vasquez
  • Patent number: 10814092
    Abstract: Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. A nitric oxide delivery system that converts nitrogen dioxide to nitric oxide employs a surface-active material, such as silica gel, coated with an aqueous solution of antioxidant, such as ascorbic acid.
    Type: Grant
    Filed: November 12, 2018
    Date of Patent: October 27, 2020
    Assignee: VERO Biotech LLC
    Inventors: David P. Rounbehler, David H. Fine
  • Patent number: 10780241
    Abstract: A device and method for treating high-altitude sickness can include a handheld device, and can deliver a therapeutic amount of nitric oxide to an individual's lungs in order to minimize or treat high-altitude sickness. The device is self-contained and portable, which allows an individual to carry and use the device in high-altitude or other low-oxygen environments.
    Type: Grant
    Filed: August 13, 2009
    Date of Patent: September 22, 2020
    Assignee: VERO Biotech LLC
    Inventors: David Fine, Gregory Vasquez, Bryan Johnson
  • Publication number: 20200180958
    Abstract: Various systems, devices, NO2 absorbents, NO2 scavengers and NO2 recuperator for generating nitric oxide are disclosed herein. According to one embodiment, an apparatus for converting nitrogen dioxide to nitric oxide can include a receptacle including an inlet, an outlet, a surface-active material coated with an aqueous solution of ascorbic acid and an absorbent wherein the inlet is configured to receive a gas flow and fluidly communicate the gas flow to the outlet through the surface-active material and the absorbent such that nitrogen dioxide in the gas flow is converted to nitric oxide.
    Type: Application
    Filed: July 15, 2019
    Publication date: June 11, 2020
    Applicant: VERO Biotech LLC
    Inventors: David H. FINE, Gregory VASQUEZ, David P. ROUNBEHLER